EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies

Francesca Coppi iD, Gianluca Pagnoni, Francesca Grossule, Ashraf Nassar, Arianna Maini iD, Giuseppe Masaracchia, Francesco Sbarra, Elisa Battigaglia, Enrico Maggio iD, Daniela Aschieri iD, Federica Moscucci iD, Marcello Pinti iD und 3 weitere

Journal of Cardiovascular Development and Disease · 05.06.2025 · 12 (6) · 213

DOI: 10.3390/jcdd12060213 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 05.06.2025. Verfasst von Francesca Coppi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Via del Pozzo 71, 41124 Modena, Italy. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The European Union-NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

: Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 50% of heart failure cases and is primarily characterized by impaired diastolic function, leading to increased ventricular filling pressures and symptoms like dyspnea and reduced exercise tolerance. Significant gender-specific differences are observed, with women, particularly post-menopausal, experiencing higher prevalence and distinct clinical profiles compared to men. Diastolic dysfunction in HFpEF involves altered cellular mechanisms such as reduced SERCA2a expression, impacting calcium handling and myocardial relaxation. Diagnostic strategies mainly employ echocardiography, including Doppler imaging, tissue Doppler imaging, and strain imaging, to assess ventricular relaxation and stiffness. However, early identification remains challenging, necessitating advanced tools like cardiac magnetic resonance and exercise stress testing for accurate diagnosis, especially in women who often present with subtle symptoms. Treatment options for HFpEF have traditionally been limited, but recent trials, notably EMPEROR-PRESERVED and DELIVER, demonstrated significant cardiovascular benefits using sodium–glucose cotransporter-2 (SGLT2) inhibitors. Additionally, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown promising results, particularly in obese patients. Despite these advances, gender differences in therapeutic response necessitate further research for personalized management strategies. Understanding sex-specific pathophysiological mechanisms and optimizing diagnostic criteria remain essential to improving prognosis and quality of life in HFpEF patients.

Schlagwörter

Stichwörter der Autor:innen

HFpEFSGLT2 inhibitorsdiastolic dysfunctionechocardiographygender differencesheart failure

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Via del Pozzo 71, 41124 Modena, Italy.
  • National Institute for Cardiovascular Research (INRC), Via Irnerio 48, 40126 Bologna, Italy.
  • Cardiology Unit of Emergency Department, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy.
  • Cardiology Division, Department of Biomedical Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via del Pozzo 71, 41124 Modena, Italy.
  • Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.
  • Dipartimento di Scienze Cliniche, "Sapienza" Università degli studi di Roma, 00185 Rome, Italy.

ORCID-Profile: Francesca Coppi, Arianna Maini, Enrico Maggio, Daniela Aschieri, Federica Moscucci, Marcello Pinti, Anna Vittoria Mattioli, Susanna Sciomer

Förderung

  • The European Union-NextGenerationEU

Zitieren

APA

Coppi, F., Pagnoni, G., Grossule, F., Nassar, A., Maini, A., Masaracchia, G., Sbarra, F., Battigaglia, E., Maggio, E., Aschieri, D., Moscucci, F., Pinti, M., Mattioli, A. V., Fedele, F., & Sciomer, S. (2025). Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies. Journal of Cardiovascular Development and Disease, 12(6), 213. https://doi.org/10.3390/jcdd12060213

Vancouver

Coppi F, Pagnoni G, Grossule F, Nassar A, Maini A, Masaracchia G, et al. Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies. Journal of Cardiovascular Development and Disease. 2025;12(6):213. doi:10.3390/jcdd12060213

BibTeX
@article{Coppi2025,
  author = {Coppi, Francesca and Pagnoni, Gianluca and Grossule, Francesca and Nassar, Ashraf and Maini, Arianna and Masaracchia, Giuseppe and Sbarra, Francesco and Battigaglia, Elisa and Maggio, Enrico and Aschieri, Daniela and Moscucci, Federica and Pinti, Marcello and Mattioli, Anna Vittoria and Fedele, Francesco and Sciomer, Susanna},
  title = {Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2025},
  volume = {12},
  number = {6},
  pages = {213},
  doi = {10.3390/jcdd12060213}
}
Kostenlos starten →